Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.37 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 50.18.
Market Cap
9.37T
Revenue
4.66T
Profits
186.68B
PE Ratio
50.18
Profit Margin
4.00%
Dividend Yield
0.38%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | 3.45% | 1,408,206 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 653.47B | 3.35% | 4,693,655 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 456.15B | 3.12% | 2,824,234 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 354.88B | -0.06% | 2,409,835 | 450.53B |
| 5 | MRK | Merck & Co., Inc. | 334.43B | -0.31% | 6,490,616 | 66.57B |
| 6 | NVS | Novartis AG | 293.68B | 1.98% | 1,114,768 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 247.93B | 2.24% | 2,151,045 | 61.37B |
| 8 | AMGN | Amgen Inc. | 230.41B | 1.62% | 1,544,552 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 218.95B | 1.13% | 619,218 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 202.99B | 2.03% | 9,077,372 | 50.34B |
| 11 | ABT | Abbott Laboratories | 195.28B | 2.25% | 4,020,228 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 177.49B | 3.04% | 3,504,190 | 30.46B |
| 13 | PFE | Pfizer Inc. | 155.69B | 1.66% | 24,920,472 | 63.70B |
| 14 | DHR | Danaher Corporation | 141.15B | -0.91% | 1,407,166 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 139.34B | 1.05% | 1,526,345 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 135.19B | 2.40% | 5,217,820 | 49.19B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 133.96B | 2.52% | 913,903 | 12.59B |
| 18 | SYK | Stryker Corporation | 127.69B | 0.37% | 2,181,292 | 25.84B |
| 19 | CVS | CVS Health Corporation | 121.13B | 0.74% | 4,041,737 | 412.65B |
| 20 | MDT | Medtronic plc | 118.31B | 2.02% | 3,710,705 | 36.36B |
| 21 | SNY | Sanofi | 106.39B | 1.43% | 2,147,742 | 55.89B |
| 22 | MCK | McKesson Corporation | 101.47B | 1.20% | 401,072 | 410.98B |
| 23 | GSK | GSK plc | 100.57B | 2.03% | 2,172,641 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 89.32B | 1.87% | 930,390 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.96B | 2.75% | 575,990 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 81.30B | 1.02% | 352,427 | 15.53B |
| 27 | CI | The Cigna Group | 73.80B | 1.43% | 496,394 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 73.68B | -1.15% | 7,819,801 | 21.00B |
| 29 | ARGX | argenx SE | 62.99B | 0.92% | 265,767 | 5.32B |
| 30 | COR | Cencora, Inc. | 60.53B | 1.50% | 511,752 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 57.04B | 4.11% | 3,053,871 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 54.53B | -0.50% | 1,020,595 | 254.25B |
| 33 | EW | Edwards Lifesciences Corporation | 52.62B | 0.53% | 1,459,780 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 49.57B | -0.06% | 958,965 | 22.48B |
| 35 | RVMD | Revolution Medicines, Inc. | 46.34B | 1.98% | 1,223,840 | - |
| 36 | HUM | Humana Inc. | 46.20B | 0.12% | 382,182 | 145.68B |
| 37 | MDLN | Medline Inc. | 45.79B | -0.14% | 4,022,497 | 29.94B |
| 38 | NTRA | Natera, Inc. | 45.15B | -0.29% | 809,823 | 2.71B |
| 39 | IDXX | IDEXX Laboratories, Inc. | 43.90B | 2.05% | 267,339 | 4.55B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.88B | 0.93% | 3,900,908 | 17.32B |
| 41 | ONC | BeOne Medicines AG | 42.12B | 2.20% | 332,112 | 6.13B |
| 42 | A | Agilent Technologies, Inc. | 42.12B | 0.46% | 814,330 | 7.23B |
| 43 | HLN | Haleon plc | 41.82B | 2.09% | 7,186,583 | 14.80B |
| 44 | IQV | IQVIA Holdings Inc. | 39.88B | 0.44% | 590,713 | 16.98B |
| 45 | VEEV | Veeva Systems Inc. | 39.78B | 2.76% | 1,052,034 | 3.32B |
| 46 | WAT | Waters Corporation | 39.65B | -1.03% | 427,153 | 4.64B |
| 47 | ALC | Alcon Inc. | 35.14B | 1.83% | 1,098,833 | 10.86B |
| 48 | RPRX | Royalty Pharma plc | 34.46B | 0.81% | 1,404,858 | 2.54B |
| 49 | DXCM | DexCom, Inc. | 33.99B | 1.46% | 1,807,604 | 4.97B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 32.92B | 0.71% | 1,767,115 | 21.27B |
| 51 | CNC | Centene Corporation | 32.32B | 1.58% | 1,770,964 | 180.30B |
| 52 | RMD | ResMed Inc. | 31.88B | 0.27% | 716,694 | 5.65B |
| 53 | BIIB | Biogen Inc. | 31.56B | 2.12% | 382,002 | 10.03B |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.74B | 2.29% | 1,056,160 | 4.80B |
| 55 | ZTS | Zoetis Inc. | 30.62B | 1.56% | 2,723,386 | 9.53B |
| 56 | ILMN | Illumina, Inc. | 28.42B | -2.56% | 827,226 | 4.49B |
| 57 | INSM | Insmed Incorporated | 28.12B | 0.36% | 686,615 | 1.14B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.07B | -1.18% | 73,320 | 4.13B |
| 59 | ROIV | Roivant Sciences Ltd. | 26.99B | 3.09% | 3,171,838 | 7.53M |
| 60 | PHG | Koninklijke Philips N.V. | 26.58B | 1.38% | 537,807 | 20.18B |
| 61 | LH | Labcorp Holdings Inc. | 26.36B | 0.52% | 308,654 | 14.35B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.10B | 0.41% | 331,247 | 11.56B |
| 63 | MRNA | Moderna, Inc. | 25.43B | -1.18% | 2,544,002 | 2.23B |
| 64 | INCY | Incyte Corporation | 25.13B | 0.40% | 502,121 | 5.82B |
| 65 | WST | West Pharmaceutical Services, Inc. | 24.42B | 0.13% | 132,419 | 3.33B |
| 66 | BNTX | BioNTech SE | 23.34B | 1.45% | 685,105 | 3.03B |
| 67 | STE | STERIS plc | 22.82B | 1.87% | 389,599 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.25B | 2.03% | 246,742 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.77B | 2.19% | 346,735 | 21.81B |
| 70 | GH | Guardant Health, Inc. | 21.51B | -0.84% | 871,647 | 1.18B |
| 71 | GMAB | Genmab A/S | 19.45B | 0.43% | 1,760,675 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.00B | 1.43% | 629,655 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.75B | 0.59% | 4,446,223 | 14.74B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 16.54B | 2.57% | 310,141 | 4.60B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.51B | -0.92% | 90,753 | 2.78B |
| 76 | ASND | Ascendis Pharma A/S | 16.47B | 1.35% | 278,572 | 1.20B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 16.16B | 3.47% | 2,099,993 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.69B | -0.06% | 656,241 | 3.37B |
| 79 | SOLV | Solventum Corporation | 14.92B | 0.93% | 624,239 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.85B | 1.38% | 1,142,454 | 4.23B |
| 81 | BAX | Baxter International Inc. | 13.42B | 0.19% | 4,491,144 | 11.47B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.39B | -2.15% | 452,605 | 4.00B |
| 83 | EXEL | Exelixis, Inc. | 13.16B | 1.49% | 778,470 | 2.44B |
| 84 | BMRN | BioMarin Pharmaceutical Inc. | 13.10B | 1.59% | 1,091,959 | 3.41B |
| 85 | ICLR | ICON Public Limited Company | 13.07B | -0.04% | 313,719 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.85B | -0.25% | 96,497 | 1.50B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.82B | 1.21% | 490,730 | 830.81M |
| 88 | RVTY | Revvity, Inc. | 12.82B | -1.11% | 324,236 | 2.91B |
| 89 | SNN | Smith & Nephew plc | 12.65B | 1.92% | 514,773 | 6.30B |
| 90 | FMS | Fresenius Medical Care AG | 12.50B | 0.38% | 434,213 | 22.19B |
| 91 | BTSG | BrightSpring Health Services, Inc. | 12.37B | -1.67% | 957,926 | 14.37B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.36B | -1.36% | 575,494 | 669.50M |
| 93 | EHC | Encompass Health Corporation | 12.12B | 0.70% | 499,028 | 6.21B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.04B | -0.73% | 174,627 | 1.28B |
| 95 | ALGN | Align Technology, Inc. | 11.97B | -1.57% | 474,726 | 4.14B |
| 96 | HALO | Halozyme Therapeutics, Inc. | 11.90B | 1.82% | 1,272,839 | 1.66B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.82B | 0.21% | 2,315,222 | 5.02B |
| 98 | GMED | Globus Medical, Inc. | 11.66B | 2.02% | 677,066 | 3.14B |
| 99 | DVA | DaVita Inc. | 11.36B | 0.83% | 241,238 | 14.01B |
| 100 | AXSM | Axsome Therapeutics, Inc. | 11.30B | -0.27% | 250,140 | 776.57M |
| 101 | TECH | Bio-Techne Corporation | 11.27B | -0.08% | 2,109,251 | 1.22B |
| 102 | GKOS | Glaukos Corporation | 10.83B | -0.99% | 383,370 | 612.84M |
| 103 | MOH | Molina Healthcare, Inc. | 10.71B | 1.26% | 352,120 | 42.47B |
| 104 | CYTK | Cytokinetics, Incorporated | 10.60B | 0.54% | 1,097,055 | 67.67M |
| 105 | ENSG | The Ensign Group, Inc. | 10.54B | 0.47% | 140,425 | 5.49B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 10.38B | -1.21% | 189,537 | 7.46M |
| 107 | SMMT | Summit Therapeutics Inc. | 10.29B | 0.94% | 3,473,895 | - |
| 108 | UHS | Universal Health Services, Inc. | 10.28B | 2.25% | 492,263 | 18.11B |
| 109 | ABVX | ABIVAX Sociรฉtรฉ Anonyme | 10.27B | -1.02% | 372,185 | 5.67M |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 10.26B | 0.58% | 2,413,110 | 3.50B |
| 111 | PODD | Insulet Corporation | 10.26B | 5.90% | 1,027,790 | 3.05B |
| 112 | PTGX | Protagonist Therapeutics, Inc. | 10.21B | -0.56% | 243,429 | 281.99M |
| 113 | APGE | Apogee Therapeutics, Inc. | 10.15B | - | 738,319 | - |
| 114 | KYMR | Kymera Therapeutics, Inc. | 10.14B | 0.40% | 335,734 | 105.00M |
| 115 | HSIC | Henry Schein, Inc. | 9.94B | -0.35% | 372,607 | 13.60B |
| 116 | IONS | Ionis Pharmaceuticals, Inc. | 9.89B | 1.55% | 1,512,574 | 874.09M |
| 117 | KRYS | Krystal Biotech, Inc. | 9.87B | -0.70% | 83,117 | 440.48M |
| 118 | OSCR | Oscar Health, Inc. | 9.77B | 0.48% | 2,310,667 | 15.32B |
| 119 | SYRE | Spyre Therapeutics, Inc. | 9.49B | 2.90% | 653,885 | - |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 9.47B | -0.27% | 111,038 | 2.59B |
| 121 | RGEN | Repligen Corporation | 9.40B | -1.50% | 296,269 | 785.10M |
| 122 | AVTR | Avantor, Inc. | 9.07B | -0.67% | 3,880,924 | 6.56B |
| 123 | IMVT | Immunovant, Inc. | 9.05B | 0.21% | 1,005,937 | - |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.02% | 2,383,505 | 42.16M |
| 125 | TEM | Tempus AI, Inc. | 8.97B | -3.76% | 2,773,795 | 1.43B |
| 126 | PCVX | Vaxcyte, Inc. | 8.91B | -0.53% | 342,023 | - |
| 127 | QGEN | Qiagen N.V. | 8.82B | 0.14% | 1,764,170 | 2.10B |
| 128 | BRKR | Bruker Corporation | 8.74B | -0.49% | 1,011,246 | 3.50B |
| 129 | HQY | HealthEquity, Inc. | 8.57B | 0.16% | 384,501 | 1.34B |
| 130 | ATR | AptarGroup, Inc. | 8.40B | 0.27% | 238,152 | 3.93B |
| 131 | ALKS | Alkermes plc | 8.33B | -0.37% | 478,898 | 1.67B |
| 132 | IBRX | ImmunityBio, Inc. | 8.11B | -3.41% | 3,751,652 | 165.79M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.99B | 0.51% | 286,762 | 239.92M |
| 134 | ORKA | Oruka Therapeutics, Inc. | 7.48B | 0.26% | 420,083 | - |
| 135 | TXG | 10x Genomics, Inc. | 7.29B | -3.50% | 1,378,506 | 616.91M |
| 136 | TWST | Twist Bioscience Corporation | 7.29B | -6.55% | 907,552 | 431.80M |
| 137 | HNGE | Hinge Health, Inc. | 7.16B | 0.93% | 813,172 | 720.06M |
| 138 | TGTX | TG Therapeutics, Inc. | 7.08B | 1.28% | 504,578 | 799.54M |
| 139 | PACS | PACS Group, Inc. | 7.00B | -0.20% | 370,944 | 5.55B |
| 140 | CHE | Chemed Corporation | 6.93B | 1.38% | 75,813 | 2.60B |
| 141 | GRFS | Grifols, S.A. | 6.79B | 0.19% | 221,361 | 8.48B |
| 142 | CGON | CG Oncology, Inc. | 6.73B | -1.60% | 337,006 | 6.23M |
| 143 | LQDA | Liquidia Corporation | 6.71B | -3.50% | 1,090,311 | 450.91M |
| 144 | SRRK | Scholar Rock Holding Corporation | 6.60B | 4.19% | 898,904 | - |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.54B | -0.64% | 1,502,143 | 1.56B |
| 146 | COGT | Cogent Biosciences, Inc. | 6.51B | -0.92% | 661,222 | - |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.49B | 0.11% | 278,598 | 618.07M |
| 148 | DNTH | Dianthus Therapeutics, Inc. | 6.46B | 0.49% | 318,144 | 1.90M |
| 149 | BLTE | Belite Bio, Inc | 6.45B | 0.48% | 65,324 | - |
| 150 | HIMS | Hims & Hers Health, Inc. | 6.45B | -3.43% | 5,364,658 | 2.58B |
| 151 | ERAS | Erasca, Inc. | 6.41B | 0.33% | 1,154,574 | - |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.20B | 0.39% | 269,048 | 840.85M |
| 153 | DFTX | Definium Therapeutics, Inc. | 6.18B | 1.59% | 1,472,247 | - |
| 154 | BLCO | Bausch + Lomb Corporation | 6.15B | 1.35% | 308,952 | 5.32B |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 6.10B | 0.95% | 603,923 | 7.50M |
| 156 | PTCT | PTC Therapeutics, Inc. | 6.06B | -0.34% | 448,938 | 1.01B |
| 157 | TVTX | Travere Therapeutics, Inc. | 6.01B | 0.41% | 582,729 | 591.33M |
| 158 | CAI | Caris Life Sciences, Inc. | 5.89B | -3.56% | 2,340,921 | 989.61M |
| 159 | AMRX | Amneal Pharmaceuticals, Inc. | 5.83B | -0.98% | 1,162,612 | 3.12B |
| 160 | RDNT | RadNet, Inc. | 5.82B | -2.52% | 227,974 | 2.27B |
| 161 | STVN | Stevanato Group S.p.A. | 5.80B | -0.14% | 307,792 | 1.40B |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 5.73B | -1.41% | 130,640 | 290.54M |
| 163 | TFX | Teleflex Incorporated | 5.60B | -0.75% | 564,339 | 2.25B |
| 164 | MMED | MiniMed Group, Inc. | 5.51B | 0.46% | 1,017,385 | 3.10B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.34B | -0.25% | 543,006 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.28B | -1.65% | 1,479,029 | 1.22B |
| 167 | ACAD | ACADIA Pharmaceuticals Inc. | 5.18B | 3.62% | 1,308,417 | 1.14B |
| 168 | CRSP | CRISPR Therapeutics AG | 5.13B | -2.17% | 998,083 | 13.39M |
| 169 | PBLS | Parabilis Medicines, Inc. | 4.88B | 6.05% | 494,965 | 148.00K |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.87B | -0.34% | 822,628 | - |
| 171 | HAE | Haemonetics Corporation | 4.77B | 16.20% | 1,590,180 | 1.35B |
| 172 | LFST | LifeStance Health Group, Inc. | 4.76B | -0.64% | 2,446,302 | 1.58B |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.76B | -0.52% | 539,527 | - |
| 174 | WAY | Waystar Holding Corp. | 4.67B | -1.42% | 928,652 | 1.21B |
| 175 | INDV | Indivior Pharmaceuticals, Inc. | 4.66B | 1.05% | 914,168 | 1.33B |
| 176 | MANE | Veradermics, Incorporated | 4.62B | 2.26% | 273,079 | - |
| 177 | ICUI | ICU Medical, Inc. | 4.62B | 1.30% | 140,030 | 2.16B |
| 178 | CELC | Celcuity Inc. | 4.59B | 1.48% | 338,181 | - |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.49B | -0.84% | 472,160 | 2.29B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.49B | -0.97% | 1,339,543 | 10.35M |
| 181 | NVST | Envista Holdings Corporation | 4.45B | 0.33% | 1,352,335 | 2.86B |
| 182 | DOCS | Doximity, Inc. | 4.43B | 1.39% | 1,873,171 | 655.57M |
| 183 | LIVN | LivaNova PLC | 4.40B | -1.93% | 400,789 | 1.47B |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.40B | 0.78% | 421,260 | - |
| 185 | ITGR | Integer Holdings Corporation | 4.25B | 0.04% | 402,657 | 1.84B |
| 186 | TNGX | Tango Therapeutics, Inc. | 4.25B | -0.36% | 1,500,531 | 53.81M |
| 187 | LEGN | Legend Biotech Corporation | 4.22B | 5.67% | 2,463,802 | 1.27B |
| 188 | BLLN | BillionToOne, Inc. | 4.22B | -4.78% | 392,015 | 397.41M |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.05B | 1.45% | 33,128 | 803.79M |
| 190 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.92B | 64.35% | 21,611,226 | -665.00K |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.92B | -0.81% | 1,156,780 | 308.08M |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.90B | -0.51% | 788,212 | - |
| 193 | DNLI | Denali Therapeutics Inc. | 3.90B | 0.08% | 537,827 | 3.60M |
| 194 | HTFL | HeartFlow, Inc. | 3.88B | 6.46% | 2,866,808 | 212.07M |
| 195 | IRTC | iRhythm Holdings, Inc. | 3.84B | -0.32% | 359,116 | 825.34M |
| 196 | GPCR | Structure Therapeutics Inc. | 3.81B | -0.61% | 391,863 | - |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.79B | 0.71% | 594,799 | 117.00M |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 3.64B | 3.31% | 407,643 | 234.13M |
| 199 | NHC | National HealthCare Corporation | 3.62B | 1.32% | 49,258 | 1.56B |
| 200 | ABCL | AbCellera Biologics Inc. | 3.61B | -0.45% | 6,592,658 | 66.17M |
| 201 | OGN | Organon & Co. | 3.59B | -0.18% | 1,185,028 | 6.13B |
| 202 | OPCH | Option Care Health, Inc. | 3.52B | 0.68% | 1,037,699 | 5.69B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | 3.83% | 1,225,399 | 463.98M |
| 204 | PLSE | Pulse Biosciences, Inc. | 3.31B | -0.75% | 390,846 | 1.19M |
| 205 | QURE | uniQure N.V. | 3.30B | -0.81% | 330,541 | 18.67M |
| 206 | VCYT | Veracyte, Inc. | 3.29B | -2.78% | 625,107 | 561.90M |
| 207 | CLDX | Celldex Therapeutics, Inc. | 3.28B | -0.33% | 558,341 | 158.00K |
| 208 | NAMS | NewAmsterdam Pharma Company N.V. | 3.25B | 0.99% | 556,892 | 7.12M |
| 209 | ALMS | Alumis Inc. | 3.22B | -2.47% | 435,089 | 7.40M |
| 210 | IOVA | Iovance Biotherapeutics, Inc. | 3.19B | -0.85% | 8,515,105 | 324.97M |
| 211 | WRBY | Warby Parker Inc. | 3.19B | 0.76% | 1,031,614 | 911.61M |
| 212 | MBX | MBX Biosciences, Inc. | 3.18B | -3.30% | 426,810 | - |
| 213 | TMDX | TransMedics Group, Inc. | 3.15B | 2.76% | 517,012 | 668.47M |
| 214 | GRAL | GRAIL, Inc. | 3.12B | -0.23% | 315,527 | 165.26M |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 3.11B | 0.36% | 437,906 | 606.33M |
| 216 | IMNM | Immunome, Inc. | 3.11B | -0.11% | 474,005 | 4.02M |
| 217 | IRON | Disc Medicine, Inc. | 3.10B | 0.74% | 241,224 | - |
| 218 | BKD | Brookdale Senior Living Inc. | 2.89B | -0.90% | 1,978,116 | 2.93B |
| 219 | ZLAB | Zai Lab Limited | 2.86B | -0.51% | 1,162,031 | 449.61M |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.84B | 1.18% | 389,978 | 830.44M |
| 221 | NRIX | Nurix Therapeutics, Inc. | 2.79B | -1.10% | 450,089 | 36.77M |
| 222 | PRVA | Privia Health Group, Inc. | 2.77B | 0.98% | 506,993 | 2.36B |
| 223 | AVAH | Aveanna Healthcare Holdings Inc. | 2.75B | -0.79% | 3,523,985 | 2.60B |
| 224 | ALHC | Alignment Healthcare, Inc. | 2.74B | -1.82% | 2,375,506 | 4.58B |
| 225 | ATAI | AtaiBeckley Inc. | 2.70B | 0.69% | 9,153,859 | 4.47M |
| 226 | AXGN | Axogen, Inc. | 2.70B | 2.01% | 622,048 | 251.17M |
| 227 | RGC | Regencell Bioscience Holdings Limited | 2.69B | 1.50% | 60,725 | - |
| 228 | TRVI | Trevi Therapeutics, Inc. | 2.69B | 2.11% | 851,803 | - |
| 229 | VRDN | Viridian Therapeutics, Inc. | 2.69B | 2.77% | 1,368,282 | 71.13M |
| 230 | BEAM | Beam Therapeutics Inc. | 2.66B | -1.88% | 842,219 | 156.04M |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.64B | 0.38% | 4,251,684 | - |
| 232 | BHC | Bausch Health Companies Inc. | 2.60B | 5.47% | 3,863,660 | 10.85B |
| 233 | ACHC | Acadia Healthcare Company, Inc. | 2.56B | -8.33% | 2,708,704 | 3.37B |
| 234 | NKTR | Nektar Therapeutics | 2.56B | 3.01% | 366,748 | 54.59M |
| 235 | NEOG | Neogen Corporation | 2.53B | -2.06% | 679,864 | 870.40M |
| 236 | RARE | Ultragenyx Pharmaceutical Inc. | 2.51B | -2.37% | 978,300 | 717.00M |
| 237 | KOD | Kodiak Sciences Inc. | 2.50B | -2.59% | 405,665 | - |
| 238 | PHVS | Pharvaris N.V. | 2.49B | 0.51% | 423,663 | - |
| 239 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.47B | -2.62% | 1,417,390 | 940.61M |
| 240 | COAG | Hemab Therapeutics Holdings, Inc. | 2.46B | -1.74% | 122,701 | - |
| 241 | GRDN | Guardian Pharmacy Services, Inc. | 2.46B | 2.05% | 239,595 | 1.46B |
| 242 | UFPT | UFP Technologies, Inc. | 2.45B | -1.60% | 61,555 | 631.64M |
| 243 | OCUL | Ocular Therapeutix, Inc. | 2.43B | 4.04% | 3,412,673 | 52.06M |
| 244 | NUVB | Nuvation Bio Inc. | 2.42B | 6.56% | 5,160,008 | 169.90M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.41B | 1.48% | 244,616 | 1.10B |
| 246 | PGEN | Precigen, Inc. | 2.40B | 2.29% | 2,831,421 | 85.72M |
| 247 | URGN | UroGen Pharma Ltd. | 2.40B | -0.28% | 533,673 | 188.73M |
| 248 | BFLY | Butterfly Network, Inc. | 2.39B | -0.67% | 3,323,763 | 112.14M |
| 249 | MLYS | Mineralys Therapeutics, Inc. | 2.36B | 2.69% | 758,792 | - |
| 250 | RAPP | Rapport Therapeutics, Inc. | 2.36B | 1.76% | 121,117 | 20.00M |
| 251 | CDNA | CareDx, Inc. | 2.35B | -1.94% | 367,346 | 458.09M |
| 252 | ATRC | AtriCure, Inc. | 2.32B | 2.08% | 542,017 | 569.62M |
| 253 | VERA | Vera Therapeutics, Inc. | 2.32B | 1.74% | 704,788 | - |
| 254 | KLRA | Kailera Therapeutics, Inc. | 2.32B | -3.46% | 1,123,555 | - |
| 255 | ALMR | Alamar Biosciences, Inc. | 2.30B | 3.21% | 278,808 | 100.42M |
| 256 | VCEL | Vericel Corporation | 2.27B | 1.86% | 312,489 | 306.30M |
| 257 | WGS | GeneDx Holdings Corp. | 2.27B | -1.69% | 262,483 | 454.43M |
| 258 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 1.94% | 252,147 | 959.90M |
| 259 | CLOV | Clover Health Investments, Corp. | 2.25B | -0.70% | 2,053,328 | 2.48B |
| 260 | ESTA | Establishment Labs Holdings Inc. | 2.25B | -1.55% | 219,886 | 245.82M |
| 261 | HCM | HUTCHMED (China) Limited | 2.22B | -0.28% | 184,839 | 549.12M |
| 262 | MESO | Mesoblast Limited | 2.22B | -2.00% | 155,731 | 65.38M |
| 263 | XRAY | DENTSPLY SIRONA Inc. | 2.22B | -0.63% | 2,416,179 | 3.64B |
| 264 | PVLA | Palvella Therapeutics, Inc. | 2.20B | -0.37% | 101,753 | - |
| 265 | ADUS | Addus HomeCare Corporation | 2.16B | 2.91% | 111,893 | 1.48B |
| 266 | ADMA | ADMA Biologics, Inc. | 2.12B | 1.55% | 791,582 | 512.28M |
| 267 | MD | Pediatrix Medical Group, Inc. | 2.11B | 1.18% | 558,999 | 1.95B |
| 268 | STOK | Stoke Therapeutics, Inc. | 2.09B | 0.78% | 445,957 | 27.59M |
| 269 | GENB | Generate Biomedicines, Inc. | 2.09B | 3.70% | 467,634 | 26.48M |
| 270 | BHVN | Biohaven Ltd. | 2.07B | -5.05% | 1,180,991 | - |
| 271 | NBTX | Nanobiotix S.A. | 2.07B | -2.46% | 140,104 | 38.27M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 2.06B | 3.61% | 445,648 | 1.00M |
| 273 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 2.32% | 535,656 | 98.34M |
| 274 | SEPN | Septerna, Inc. | 2.05B | -0.86% | 190,317 | 98.88M |
| 275 | NEO | NeoGenomics, Inc. | 2.05B | -1.49% | 557,811 | 766.30M |
| 276 | GHRS | GH Research PLC | 2.04B | -0.67% | 176,473 | - |
| 277 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | - | 472,395 | 311.51M |
| 278 | TSHA | Taysha Gene Therapies, Inc. | 2.03B | 0.48% | 998,241 | 5.49M |
| 279 | NVCR | NovoCure Limited | 2.02B | -1.08% | 441,651 | 699.19M |
| 280 | ASTH | Astrana Health, Inc. | 2.00B | -1.48% | 206,706 | 3.84B |
| 281 | PGNY | Progyny, Inc. | 1.98B | 1.82% | 597,330 | 1.31B |
| 282 | KARD | Kardigan, Inc. | 1.96B | 1.92% | 163,408 | - |
| 283 | DMRA | Damora Therapeutics, Inc. | 1.94B | 1.25% | 262,900 | - |
| 284 | FBRX | Forte Biosciences, Inc. | 1.94B | -0.03% | 438,649 | - |
| 285 | CMPS | COMPASS Pathways plc | 1.93B | 1.75% | 2,673,545 | - |
| 286 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | -0.33% | 757,457 | 1.97B |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.90B | 3.02% | 412,908 | 481.07M |
| 288 | LMAT | LeMaitre Vascular, Inc. | 1.87B | -0.84% | 268,525 | 262.43M |
| 289 | XNCR | Xencor, Inc. | 1.86B | 8.43% | 885,943 | 104.97M |
| 290 | IMCR | Immunocore Holdings plc | 1.86B | 3.17% | 389,168 | 430.78M |
| 291 | ZYME | Zymeworks Inc. | 1.86B | 3.60% | 378,499 | 37.13M |
| 292 | TRLV | Trulieve Cannabis Corp. | 1.86B | 1.80% | 737,354 | 1.14B |
| 293 | SGRY | Surgery Partners, Inc. | 1.85B | -0.56% | 897,522 | 3.37B |
| 294 | LKFT | Lakefront Biotherapeutics NV | 1.84B | 1.13% | 238,299 | 1.13B |
| 295 | PRGO | Perrigo Company plc | 1.82B | 2.26% | 1,178,237 | 4.14B |
| 296 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 0.61% | 629,995 | 252.25M |
| 297 | ETON | Eton Pharmaceuticals, Inc. | 1.77B | 0.42% | 564,150 | 105.60M |
| 298 | AVLN | Avalyn Pharma Inc. | 1.76B | 3.58% | 136,381 | - |
| 299 | ANAB | AnaptysBio, Inc. | 1.74B | -1.29% | 142,263 | 232.39M |
| 300 | BRVE | Braveheart Bio, Inc. | 1.72B | -3.29% | 145,944 | - |
| 301 | BLFS | BioLife Solutions, Inc. | 1.71B | -1.21% | 294,135 | 106.69M |
| 302 | FTRE | Fortrea Holdings Inc. | 1.69B | -1.93% | 405,738 | 2.68B |
| 303 | INSP | Inspire Medical Systems, Inc. | 1.66B | 0.09% | 232,020 | 898.74M |
| 304 | TNDM | Tandem Diabetes Care, Inc. | 1.65B | 6.31% | 1,626,277 | 1.04B |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.64B | 0.99% | 157,334 | 978.38M |
| 306 | BCAX | Bicara Therapeutics Inc. | 1.64B | -0.48% | 203,220 | - |
| 307 | OMCL | Omnicell, Inc. | 1.64B | -0.19% | 693,577 | 1.25B |
| 308 | AAPG | Ascentage Pharma Group International | 1.64B | -1.04% | 6,481 | 82.08M |
| 309 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | 0.07% | 146,496 | 95.13M |
| 310 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | -2.89% | 13,435,831 | 54.86M |
| 311 | NTLA | Intellia Therapeutics, Inc. | 1.62B | -4.43% | 2,379,026 | 59.51M |
| 312 | TRAX | First Tracks Biotherapeutics, Inc. | 1.62B | 3.81% | 435,993 | - |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.62B | 4.04% | 443,042 | 20.00M |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.61B | 3.58% | 1,031,620 | 335.41M |
| 315 | AGL | agilon health, inc. | 1.61B | -1.29% | 144,563 | 5.92B |
| 316 | VIR | Vir Biotechnology, Inc. | 1.60B | 0.85% | 788,997 | 303.23M |
| 317 | LBRX | LB Pharmaceuticals Inc | 1.57B | 5.54% | 390,983 | - |
| 318 | TYRA | Tyra Biosciences, Inc. | 1.55B | -0.84% | 239,094 | - |
| 319 | ARDT | Ardent Health, Inc. | 1.55B | 0.73% | 117,633 | 6.41B |
| 320 | SLBT | SL Science Holding Limited | 1.54B | -2.17% | 15,988 | 3.27M |
| 321 | INVA | Innoviva, Inc. | 1.53B | 1.22% | 251,379 | 440.00M |
| 322 | HCSG | Healthcare Services Group, Inc. | 1.52B | 2.64% | 344,339 | 1.86B |
| 323 | FRNM | Freenome, Inc. | 1.52B | 3.35% | 1,225,250 | 34.24M |
| 324 | INNV | InnovAge Holding Corp. | 1.51B | 4.22% | 123,090 | 949.17M |
| 325 | ABSI | Absci Corporation | 1.51B | -5.09% | 1,995,863 | 1.56M |
| 326 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.49B | 1.32% | 1,102,068 | 208.78M |
| 327 | CNMD | CONMED Corporation | 1.49B | 1.16% | 290,798 | 1.37B |
| 328 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 4.14% | 213,131 | - |
| 329 | PSNL | Personalis, Inc. | 1.49B | 0.36% | 500,448 | 69.67M |
| 330 | ENOV | Enovis Corporation | 1.48B | 3.96% | 468,265 | 2.30B |
| 331 | JBIO | Jade Biosciences, Inc. | 1.48B | -0.90% | 427,429 | - |
| 332 | ATEC | Alphatec Holdings, Inc. | 1.48B | 1.06% | 738,228 | 815.05M |
| 333 | HROW | Harrow, Inc. | 1.47B | -0.75% | 631,913 | 275.59M |
| 334 | REPL | Replimune Group, Inc. | 1.46B | 5.88% | 1,371,986 | - |
| 335 | OMDA | Omada Health, Inc. | 1.45B | 0.04% | 331,836 | 309.76M |
| 336 | ORIC | ORIC Pharmaceuticals, Inc. | 1.45B | 4.48% | 599,130 | - |
| 337 | AZTA | Azenta, Inc. | 1.45B | -1.52% | 335,320 | 613.81M |
| 338 | ALVO | Alvotech | 1.41B | 1.80% | 564,776 | 562.04M |
| 339 | AORT | Artivion, Inc. | 1.41B | 2.05% | 488,627 | 471.47M |
| 340 | PAHC | Phibro Animal Health Corporation | 1.41B | 0.03% | 49,146 | 1.50B |
| 341 | VOR | Vor Biopharma Inc. | 1.40B | 2.52% | 575,707 | - |
| 342 | MLTX | MoonLake Immunotherapeutics | 1.39B | - | 592,596 | - |
| 343 | PNTG | The Pennant Group, Inc. | 1.38B | 0.78% | 119,418 | 1.10B |
| 344 | INBX | Inhibrx Biosciences, Inc. | 1.38B | 1.71% | 224,528 | 1.30M |
| 345 | AKTS | Aktis Oncology, Inc. | 1.38B | 0.04% | 80,672 | 10.06M |
| 346 | IART | Integra LifeSciences Holdings Corporation | 1.37B | -0.11% | 306,544 | 1.65B |
| 347 | SVRA | Savara Inc. | 1.36B | - | 988,506 | - |
| 348 | ANRO | Alto Neuroscience, Inc. | 1.35B | 2.08% | 337,530 | - |
| 349 | MGTX | MeiraGTx Holdings plc | 1.34B | 1.38% | 403,873 | 397.50M |
| 350 | AMN | AMN Healthcare Services, Inc. | 1.33B | -0.64% | 221,067 | 3.43B |
| 351 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | 0.05% | 405,777 | - |
| 352 | DRTS | Alpha Tau Medical Ltd. | 1.32B | 0.78% | 321,583 | - |
| 353 | SDGR | Schrรถdinger, Inc. | 1.31B | 0.46% | 377,633 | 259.04M |
| 354 | MNKD | MannKind Corporation | 1.31B | 4.10% | 2,993,503 | 393.63M |
| 355 | NVAX | Novavax, Inc. | 1.30B | -1.98% | 1,167,167 | 413.80M |
| 356 | GLUE | Monte Rosa Therapeutics, Inc. | 1.30B | -1.04% | 758,765 | 28.73M |
| 357 | SPTX | Seaport Therapeutics, Inc. | 1.28B | -1.72% | 75,140 | - |
| 358 | NUTX | Nutex Health Inc. | 1.28B | -0.83% | 94,437 | 846.72M |
| 359 | GDRX | GoodRx Holdings, Inc. | 1.27B | 0.27% | 757,024 | 785.23M |
| 360 | APMD | Apnimed, Inc. | 1.27B | -2.15% | 309,170 | 120.15M |
| 361 | LTGO | Latigo Biotherapeutics, Inc. | 1.26B | 2.90% | 182,982 | - |
| 362 | OMER | Omeros Corporation | 1.25B | -0.78% | 833,914 | 38.42M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -0.87% | 354,318 | - |
| 364 | IMTX | Immatics N.V. | 1.24B | -2.11% | 515,645 | 43.00M |
| 365 | STAA | STAAR Surgical Company | 1.24B | 2.24% | 598,768 | 339.59M |
| 366 | CERT | Certara, Inc. | 1.22B | 0.31% | 1,298,241 | 421.75M |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | 1.14% | 543,571 | 337.34M |
| 368 | BVS | Bioventus Inc. | 1.22B | 4.25% | 361,892 | 581.85M |
| 369 | USPH | U.S. Physical Therapy, Inc. | 1.18B | 0.96% | 79,170 | 804.27M |
| 370 | TDOC | Teladoc Health, Inc. | 1.18B | -0.76% | 2,241,384 | 2.49B |
| 371 | CRON | Cronos Group Inc. | 1.16B | 1.90% | 944,305 | 179.09M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.15B | 1.69% | 233,003 | 1.04B |
| 373 | IRMD | IRADIMED CORPORATION | 1.12B | -0.65% | 44,218 | 86.34M |
| 374 | IVA | Inventiva S.A. | 1.11B | -1.28% | 691,200 | 7.94M |
| 375 | GMRS | GMR Solutions Inc. | 1.10B | 2.24% | 431,864 | 5.88B |
| 376 | KURA | Kura Oncology, Inc. | 1.10B | 9.22% | 3,220,781 | 77.23M |
| 377 | SANA | Sana Biotechnology, Inc. | 1.10B | -0.54% | 1,593,955 | - |
| 378 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.08B | 3.42% | 2,334,930 | 41.47M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.07B | -0.20% | 833,433 | 59.00K |
| 380 | ODTX | Odyssey Therapeutics, Inc. | 1.04B | 4.07% | 147,498 | 99.00K |
| 381 | WVE | Wave Life Sciences Ltd. | 1.04B | 3.34% | 1,798,210 | 65.37M |
| 382 | JANX | Janux Therapeutics, Inc. | 1.02B | 2.95% | 323,379 | 24.00M |
| 383 | OPK | OPKO Health, Inc. | 1.02B | - | 1,084,862 | 587.90M |
| 384 | CLYM | Climb Bio, Inc. | 1.00B | 0.23% | 727,390 | - |
| 385 | ATTO | Attovia Therapeutics, Inc. | 998.27M | 2.16% | 126,989 | 1.35M |
| 386 | ANNX | Annexon, Inc. | 997.19M | 2.53% | 1,002,545 | - |
| 387 | GERN | Geron Corporation | 979.77M | -0.33% | 2,122,887 | 204.56M |
| 388 | AHG | Akso Health Group | 976.64M | -5.79% | 4,839 | 13.83M |
| 389 | ARDX | Ardelyx, Inc. | 975.57M | -3.57% | 2,953,906 | 450.89M |
| 390 | SLDB | Solid Biosciences Inc. | 969.32M | -0.66% | 341,310 | - |
| 391 | PCRX | Pacira BioSciences, Inc. | 953.70M | 2.95% | 205,779 | 746.16M |
| 392 | ABUS | Arbutus Biopharma Corporation | 952.64M | 2.23% | 1,043,482 | 181.72M |
| 393 | DSGN | Design Therapeutics, Inc. | 950.62M | 0.60% | 491,971 | - |
| 394 | CBLL | CeriBell, Inc. | 940.65M | 0.45% | 309,040 | 101.96M |
| 395 | AVR | Anteris Technologies Global Corp. | 940.47M | 2.44% | 459,387 | 2.24M |
| 396 | OLMA | Olema Pharmaceuticals, Inc. | 934.47M | -0.84% | 651,044 | - |
| 397 | COLL | Collegium Pharmaceutical, Inc. | 925.23M | 1.25% | 538,378 | 808.21M |
| 398 | ACRS | Aclaris Therapeutics, Inc. | 924.41M | 6.08% | 1,508,717 | 8.22M |
| 399 | QDEL | QuidelOrtho Corporation | 917.54M | -8.23% | 781,909 | 2.67B |
| 400 | CADL | Candel Therapeutics, Inc. | 913.63M | -1.81% | 533,085 | - |
| 401 | ANL | Adlai Nortye Ltd. | 911.55M | 6.11% | 139,718 | 18.06M |
| 402 | AMPH | Amphastar Pharmaceuticals, Inc. | 908.19M | 2.35% | 292,264 | 730.02M |
| 403 | FTH | Faeth Therapeutics, Inc. | 900.02M | 6.29% | 285,117 | - |
| 404 | CSTL | Castle Biosciences, Inc. | 887.77M | -2.97% | 254,416 | 357.28M |
| 405 | TBPH | Theravance Biopharma, Inc. | 880.02M | 0.18% | 73,048 | 104.31M |
| 406 | DBVT | DBV Technologies S.A. | 871.61M | -0.75% | 146,841 | 5.04M |
| 407 | TALK | Talkspace, Inc. | 870.58M | - | 2,409,426 | 245.73M |
| 408 | SGP | SpyGlass Pharma, Inc. | 868.98M | 0.78% | 39,009 | - |
| 409 | INMD | InMode Ltd. | 861.64M | -0.20% | 218,080 | 374.63M |
| 410 | SIBN | SI-BONE, Inc. | 861.41M | 2.84% | 342,041 | 213.60M |
| 411 | BBNX | Beta Bionics, Inc. | 848.96M | 7.46% | 1,381,694 | 119.01M |
| 412 | GLAS | Glass House Brands Inc. | 847.50M | -2.48% | 221,203 | 177.68M |
| 413 | AURA | Aura Biosciences, Inc. | 846.23M | 6.25% | 463,495 | - |
| 414 | SLN | Silence Therapeutics plc | 844.14M | -2.30% | 1,365,468 | 615.00K |
| 415 | IMMX | Immix Biopharma, Inc. | 843.45M | 3.97% | 992,044 | - |
| 416 | PHAR | Pharming Group N.V. | 839.53M | 0.93% | 20,076 | 366.48M |
| 417 | HSTM | HealthStream, Inc. | 836.85M | 2.14% | 114,246 | 321.12M |
| 418 | OBX | Obsidian Therapeutics, Inc. | 836.20M | 10.07% | 100,350 | - |
| 419 | OCS | Oculis Holding AG | 813.94M | 0.34% | 141,343 | 1.45M |
| 420 | RIGL | Rigel Pharmaceuticals, Inc. | 809.59M | 2.10% | 171,684 | 276.79M |
| 421 | MNPR | Monopar Therapeutics Inc. | 801.63M | 2.52% | 106,204 | - |
| 422 | FDMT | 4D Molecular Therapeutics, Inc. | 799.38M | -0.52% | 1,172,028 | 92.01M |
| 423 | VREX | Varex Imaging Corporation | 778.47M | 0.05% | 435,604 | 865.00M |
| 424 | AHCO | AdaptHealth Corp. | 775.77M | 0.09% | 1,793,611 | 3.36B |
| 425 | DRUG | Bright Minds Biosciences Inc. | 769.03M | 5.56% | 105,126 | - |
| 426 | ACHV | Achieve Life Sciences, Inc. | 761.99M | -1.27% | 740,308 | - |
| 427 | SSII | SS Innovations International, Inc. | 743.43M | -1.33% | 34,161 | 52.40M |
| 428 | STTK | Shattuck Labs, Inc. | 741.68M | - | 325,178 | 1.00M |
| 429 | CTMX | CytomX Therapeutics, Inc. | 736.50M | -2.03% | 1,830,530 | 18.30M |
| 430 | GYRE | Gyre Therapeutics, Inc. | 732.69M | 1.47% | 34,664 | 109.82M |
| 431 | PHAT | Phathom Pharmaceuticals, Inc. | 732.35M | -0.65% | 678,693 | 239.66M |
| 432 | RGNX | REGENXBIO Inc. | 729.45M | -2.47% | 423,350 | 174.48M |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 719.16M | -0.77% | 223,642 | - |
| 434 | HELP | Cybin Inc. | 715.92M | -0.17% | 722,603 | - |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 714.66M | -0.80% | 919,460 | 389.32M |
| 436 | NGNE | Neurogene Inc. | 714.51M | -2.66% | 48,175 | 925.00K |
| 437 | TECX | Tectonic Therapeutic, Inc. | 713.94M | 7.89% | 371,219 | - |
| 438 | CBIO | Crescent Biopharma, Inc. | 711.57M | -4.89% | 112,094 | 11.88M |
| 439 | ALLO | Allogene Therapeutics, Inc. | 708.26M | -1.44% | 3,315,522 | 4.64M |
| 440 | EVO | Evotec SE | 706.63M | -3.57% | 16,383 | 819.47M |
| 441 | PHR | Phreesia, Inc. | 705.27M | -1.47% | 1,134,438 | 495.59M |
| 442 | ZVRA | Zevra Therapeutics, Inc. | 688.26M | 0.52% | 621,129 | 136.07M |
| 443 | VSTM | Verastem, Inc. | 679.68M | 4.53% | 2,019,926 | 87.53M |
| 444 | NVCT | Nuvectis Pharma, Inc. | 677.04M | 8.91% | 163,462 | - |
| 445 | AGMB | AgomAb Therapeutics NV | 673.71M | - | 23,819 | - |
| 446 | SOPH | SOPHiA GENETICS SA | 668.25M | 2.88% | 371,757 | 86.17M |
| 447 | KIDS | OrthoPediatrics Corp. | 665.54M | 3.20% | 120,495 | 252.72M |
| 448 | SGMT | Sagimet Biosciences Inc. | 658.26M | 1.53% | 735,521 | - |
| 449 | STLN | Starling Oncology, Inc. | 656.34M | 2.06% | 683,164 | 587.24M |
| 450 | ANGO | AngioDynamics, Inc. | 655.53M | 1.21% | 177,077 | 320.17M |
| 451 | ASMB | Assembly Biosciences, Inc. | 651.54M | 6.63% | 390,495 | 74.85M |
| 452 | VALN | Valneva SE | 647.09M | -1.63% | 55,114 | 163.30M |
| 453 | CRMD | CorMedix Inc. | 631.35M | 5.61% | 1,279,313 | 462.25M |
| 454 | SPRY | ARS Pharmaceuticals, Inc. | 629.00M | 1.36% | 1,488,371 | 116.93M |
| 455 | MDXG | MiMedx Group, Inc. | 622.40M | 1.91% | 849,904 | 355.17M |
| 456 | EIKN | Eikon Therapeutics, Inc. | 621.27M | 9.55% | 564,964 | - |
| 457 | AUTL | Autolus Therapeutics plc | 608.18M | 0.22% | 2,856,671 | 117.39M |
| 458 | CTKB | Cytek Biosciences, Inc. | 607.67M | -1.37% | 430,976 | 206.71M |
| 459 | ARVN | Arvinas, Inc. | 607.44M | 0.98% | 324,886 | 316.70M |
| 460 | TLRY | Tilray Brands, Inc. | 604.84M | -0.45% | 2,377,844 | 915.45M |
| 461 | CTEV | Claritev Corporation | 602.48M | 0.57% | 75,325 | 994.67M |
| 462 | BWAY | BrainsWay Ltd. | 601.35M | -5.23% | 95,745 | 60.70M |
| 463 | PRLD | Prelude Therapeutics Incorporated | 594.28M | 2.49% | 169,554 | 22.42M |
| 464 | DCTH | Delcath Systems, Inc. | 583.63M | -1.35% | 357,587 | 95.42M |
| 465 | WEAV | Weave Communications, Inc. | 582.79M | 31.74% | 45,696,570 | 257.79M |
| 466 | ALT | Altimmune, Inc. | 581.61M | -0.33% | 1,603,651 | 31.00K |
| 467 | ARTV | Artiva Biotherapeutics, Inc. | 574.95M | 0.17% | 186,054 | 251.00K |
| 468 | OABI | OmniAb, Inc. | 572.84M | 3.14% | 2,838,708 | 38.46M |
| 469 | CERS | Cerus Corporation | 572.33M | -4.38% | 2,011,360 | 221.55M |
| 470 | OVID | Ovid Therapeutics Inc. | 560.50M | -0.69% | 1,497,518 | 1.58M |
| 471 | ZURA | Zura Bio Limited | 554.37M | 1.85% | 739,116 | - |
| 472 | AQST | Aquestive Therapeutics, Inc. | 549.74M | 2.10% | 4,606,241 | 54.09M |
| 473 | CTNM | Contineum Therapeutics, Inc. | 547.76M | 0.21% | 264,903 | - |
| 474 | MPLT | MapLight Therapeutics, Inc. | 546.79M | 4.85% | 323,075 | - |
| 475 | PRME | Prime Medicine, Inc. | 544.39M | -3.47% | 897,421 | 4.07M |
| 476 | EOLS | Evolus, Inc. | 544.26M | 6.05% | 469,580 | 316.49M |
| 477 | TCMD | Tactile Systems Technology, Inc. | 541.39M | -2.81% | 463,329 | 350.31M |
| 478 | KYTX | Kyverna Therapeutics, Inc. | 525.67M | -5.03% | 682,342 | - |
| 479 | EVH | Evolent Health, Inc. | 522.33M | 4.76% | 2,513,332 | 2.10B |
| 480 | EVMN | Evommune, Inc. | 520.43M | 0.63% | 244,480 | 10.00M |
| 481 | CCCC | C4 Therapeutics, Inc. | 518.55M | -1.17% | 2,333,145 | 35.04M |
| 482 | RLMD | Relmada Therapeutics, Inc. | 514.68M | 1.15% | 466,615 | - |
| 483 | SCTX | Scribe Therapeutics Inc. | 514.43M | 28.69% | 430,163 | 36.28M |
| 484 | FLGT | Fulgent Genetics, Inc. | 510.13M | -0.64% | 93,503 | 323.93M |
| 485 | SRTA | Strata Critical Medical, Inc. | 506.03M | -3.05% | 663,260 | 255.98M |
| 486 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 487 | ENTX | Entera Bio Ltd. | 502.11M | - | 173,133 | 42.00K |
| 488 | NPCE | NeuroPace, Inc. | 499.07M | 1.82% | 91,383 | 106.99M |
| 489 | BLSM | BlossomHill Therapeutics, Inc. | 494.90M | -1.40% | 243,163 | - |
| 490 | CABA | Cabaletta Bio, Inc. | 490.83M | 0.17% | 5,863,028 | - |
| 491 | NRC | NRC Health | 485.52M | 0.83% | 79,210 | 140.00M |
| 492 | RZLT | Rezolute, Inc. | 485.25M | -0.75% | 473,846 | - |
| 493 | BIOA | BioAge Labs, Inc. | 482.15M | 1.01% | 294,621 | 10.36M |
| 494 | PBYI | Puma Biotechnology, Inc. | 480.58M | 5.56% | 155,412 | 231.24M |
| 495 | EYPT | EyePoint, Inc. | 472.87M | 12.63% | 13,984,304 | 2.79M |
| 496 | CLPT | ClearPoint Neuro, Inc. | 465.80M | -1.48% | 155,263 | 42.28M |
| 497 | SENS | Senseonics Holdings, Inc. | 465.29M | 9.59% | 980,599 | 48.55M |
| 498 | SGHT | Sight Sciences, Inc. | 457.23M | 0.73% | 215,904 | 83.38M |
| 499 | OCGN | Ocugen, Inc. | 456.10M | -2.18% | 2,095,673 | 4.58M |
| 500 | QTTB | Q32 Bio Inc. | 453.98M | -4.39% | 209,496 | 53.74M |